Use of adenoviral vectors to deliver donor templates for genome editing facilitates precise genome modifications in human cells. This has implications for both basic and translational applications of rare-cleaving nuclease technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Segal, D.J. & Meckler, J.F. Annu. Rev. Genomics Hum. Genet. 14, 135–158 (2013).
Voytas, D.F. Annu. Rev. Plant Biol. 64, 327–350 (2013).
Kim, H. & Kim, J.-S. Nat. Rev. Genet. 15, 321–334 (2014).
Esvelt, K.M. & Wang, H.H. Mol. Syst. Biol. 9, 641 (2013).
Holkers, M. et al. Nat. Methods 11, 1051–1057 (2014).
Anguela, X.M. et al. Blood 122, 3283–3287 (2013).
Li, H. et al. Nature 475, 217–221 (2011).
Perez-Pinera, P., Ousterout, D.G., Brown, M.T. & Gersbach, C.A. Nucleic Acids Res. 40, 3741–3752 (2012).
Beard, B.C., Adair, J.E., Trobridge, G.D. & Kiem, H.-P. Methods Mol. Biol. 1185, 321–344 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Yes there is potential Competing Interest.
I have equity in Bluebird Bio. I am on the Bluebird Bio Scientific Advisory Board, and consult for Bluebird Bio.
Rights and permissions
About this article
Cite this article
Scharenberg, A. Gene targeting with nucleases: capped templates, semper fidelis?. Nat Methods 11, 1029–1030 (2014). https://doi.org/10.1038/nmeth.3110
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth.3110